Mode
Text Size
Log in / Sign up

Angina

Part of Myocardial ischemia

6 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Angina

27 trials tracked for Angina: 8 in phase 3 or 4 and 2 with published results. The most-cited published study has 49 citations.

27Trials tracked
8Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 4 Phase 3 4 Phase 2 5 Other / NA 14
  1. Phase 3 Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD Completed · 49 cited
  2. Phase 4 Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina Completed · 23 cited
  3. Phase 4 Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome Completed
  4. Phase 4 Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention Completed
  5. Phase 4 Effects of Nicorandil on Angina Symptoms in Patients With Coronary Slow Flow Completed
  6. Phase 3 Myocardial Ischemia and Transfusion Pilot Completed
Show 21 more trials
  1. Phase 3 Ranolazine and Pulmonary Hypertension Completed
  2. Phase 3 An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome Completed
  3. Phase 2 Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention Completed
  4. Phase 2 Treadmill Cardiovascular Safety Study of Erenumab (AMG 334) Completed
  5. Phase 2 Ranolazine Among Unrevascularized Chronic Stable Angina Patients Completed
  6. Phase 2 Aspirin Resistance and Percutaneous Coronary Intervention (PCI) Completed
  7. Phase 2 Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study) Completed
  8. N/A Plasmonic Nanophotothermal Therapy of Atherosclerosis Completed
  9. N/A Correlational Study on the Biomarkers Application to the Prediction and Diagnosis of Cardiovascular Diseases Completed
  10. N/A Technology-Based Intervention to Promote Heart Health After Cardiac Rehab (Mobile4Heart) Completed
  11. N/A Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina Completed
  12. N/A Outcome of Coronary High Angulated Bifurcation Lesions Treated With Kissing Ballooning or Sequential Ballooning Techniques Completed
  13. N/A PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evaluation of FFR Measurements Completed
  14. N/A XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan Completed
  15. N/A Comparative Effectiveness of Decision Aids for Stable Chest Discomfort Completed
  16. N/A Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity) Completed
  17. N/A XIENCE PRIME Japan Post-Marketing Surveillance (PMS) Completed
  18. N/A Antiplatelet and Anti-inflammatory Effects of Statins and Ezetimibe Completed
  19. N/A Early Versus Delayed Timing of Intervention in Patients With Acute Coronary Syndromes Completed
  20. N/A MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms Completed
  21. N/A MBCT Delivered Via Group Videoconferencing for ACS Syndrome Patients With Depressive Symptoms Completed

Showing the 27 most-cited and recently-updated of 27 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Angina

Did intensive medical treatment fail to help women with suspected ANOCA?

Intensive medical treatment did not reduce heart events in women with suspected ANOCA, but using cardiac MRI to guide care improved satisfaction and diagnosis accuracy.

Full answer →
Will intensive medical treatment reduce my major adverse cardiovascular events?

For women with ANOCA/INOCA, intensive medical treatment did not reduce major adverse cardiovascular events over 2.5 years compared to usual care.

Full answer →